Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment

• Jill K. Wieser, MD,
• Gina J. Kuehn, MD,
• James C. Prezzano, MD,
• Elizabeth H. Cusick, MD,
• Julia D. Stiegler, MD,
• Glynis A. Scott, MD,
• Jane L. Liesveld, MD,
• Lisa A. Beck, MD

Affiliations

Jill K. Wieser, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York; Correspondence to: Jill K. Wieser, MD, URMC, Department of Dermatology, 40 Celebration Dr, Rochester, NY 14642.

Gina J. Kuehn, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York

James C. Prezzano, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York

Elizabeth H. Cusick, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York

Julia D. Stiegler, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York

Glynis A. Scott, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York

Jane L. Liesveld, MD

Department of Medicine–Hematology/Oncology, University of Rochester Medical Center, Rochester, New York

Lisa A. Beck, MD

Department of Dermatology, University of Rochester Medical Center, Rochester, New York